Shares of Jiangsu Hengrui Pharmaceuticals soared Friday morning, as more companies seek to tap Hong Kong’s capital markets.

Jiangsu Hengrui Pharmaceuticals Co (HK:1276) made a powerful entrance on the Hong Kong Stock Exchange on Friday, with shares soaring over 37% in early trading after a $1.27 billion IPO. The offering was priced

Jiangsu Hengrui Pharmaceuticals, one of China’s largest drug makers, began trading on the Hong Kong stock exchange on Friday, marking a key step in its international expansion and giving a boost to the city’s recovering initial public offerings (IPO) market.